Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Bodei

Showing results (31-40 of 184) with videos related to

Pageof 19
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 3, 2017
Somatostatin Receptor 2-Targeting CompoundsDaan A Smit Duijzentkunst, Dik J Kwekkeboom, Lisa Bodei
Frontiers of Hormone Research|August 26, 2015
Peptide Receptor Radionuclide Therapy of Neuroendocrine TumorsLisa Bodei, Mark Kidd, Vikas Prasad, et al.
Cellular and Molecular Gastroenterology and Hepatology|February 18, 2017
Decoding the Molecular and Mutational Ambiguities of Gastroenteropancreatic Neuroendocrine Neoplasm PathobiologyMark Kidd, Irvin M Modlin, Lisa Bodei, et al.
BMC Cancer|August 7, 2014
Blood transcript analysis and metastatic recurrent small bowel carcinoid managementIrvin M Modlin, Ignat Drozdov, Lisa Bodei, et al.
The Journal of Clinical Endocrinology and Metabolism|October 26, 2018
Blood mRNA Measurement (NETest) for Neuroendocrine Tumor Diagnosis of Image-Negative Liver Metastatic DiseaseAnna Malczewska, Lisa Bodei, Mark Kidd, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 7, 2006
Dosimetry in Peptide radionuclide receptor therapy: a reviewMarta Cremonesi, Mahila Ferrari, Lisa Bodei, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 5, 2003
Radiotoxicity of iodine-125 and other auger-electron-emitting radionuclides: background to therapyS James Adelstein, Amin I Kassis, Lisa Bodei, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 27, 2021
Imaging and liquid biopsy in the prediction and evaluation of response to PRRT in neuroendocrine tumors: implications for patient managementWolfgang Roll, Matthias Weckesser, Robert Seifert, et al.
Nature Reviews. Drug Discovery|September 8, 2020
Author Correction: Radiopharmaceutical therapy in cancer: clinical advances and challengesGeorge Sgouros, Lisa Bodei, Michael R McDevitt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 27, 2014
PRRT: Defining the paradigm shift to achieve standardization and individualizationLisa Bodei, Mark Kidd, Richard P Baum, et al.
Pageof 19

Showing results (31-40 of 184) with videos related to

Sort By:
Pageof 19
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 3, 2017
Somatostatin Receptor 2-Targeting CompoundsDaan A Smit Duijzentkunst, Dik J Kwekkeboom, Lisa Bodei
Frontiers of Hormone Research|August 26, 2015
Peptide Receptor Radionuclide Therapy of Neuroendocrine TumorsLisa Bodei, Mark Kidd, Vikas Prasad, et al.
Cellular and Molecular Gastroenterology and Hepatology|February 18, 2017
Decoding the Molecular and Mutational Ambiguities of Gastroenteropancreatic Neuroendocrine Neoplasm PathobiologyMark Kidd, Irvin M Modlin, Lisa Bodei, et al.
BMC Cancer|August 7, 2014
Blood transcript analysis and metastatic recurrent small bowel carcinoid managementIrvin M Modlin, Ignat Drozdov, Lisa Bodei, et al.
The Journal of Clinical Endocrinology and Metabolism|October 26, 2018
Blood mRNA Measurement (NETest) for Neuroendocrine Tumor Diagnosis of Image-Negative Liver Metastatic DiseaseAnna Malczewska, Lisa Bodei, Mark Kidd, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 7, 2006
Dosimetry in Peptide radionuclide receptor therapy: a reviewMarta Cremonesi, Mahila Ferrari, Lisa Bodei, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 5, 2003
Radiotoxicity of iodine-125 and other auger-electron-emitting radionuclides: background to therapyS James Adelstein, Amin I Kassis, Lisa Bodei, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 27, 2021
Imaging and liquid biopsy in the prediction and evaluation of response to PRRT in neuroendocrine tumors: implications for patient managementWolfgang Roll, Matthias Weckesser, Robert Seifert, et al.
Nature Reviews. Drug Discovery|September 8, 2020
Author Correction: Radiopharmaceutical therapy in cancer: clinical advances and challengesGeorge Sgouros, Lisa Bodei, Michael R McDevitt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 27, 2014
PRRT: Defining the paradigm shift to achieve standardization and individualizationLisa Bodei, Mark Kidd, Richard P Baum, et al.
Pageof 19